Drug-Device Combination Products Market Share of Top 3 and Top 5 Manufacturers Analysis with Forecast to 2025

The global drug-device combination products market was valued at $81,374 million in 2017 and is projected to reach $139,193 million by 2025 at a CAGR of 6.9% from 2018 to 2025.

The key players of this market include Abbott Laboratories, Medtronic plc, Smith & Nephew plc, Boston Scientific Corporation, GlaxoSmithKline plc, Becton, Dickinson and Company, Johnson & Johnson, Novartis AG, Bayer AG, and Baxter International, Inc.

The other players in the value chain include B. Braun Melsungen AG, Cook Medical, ICU Medical, Inc., Moog, Inc., and C.R. Bard, Inc. These players are not profiled in the report and the same can be included on request.

Get Sample PDF Brochure : https://www.alliedmarketresearch.com/request-sample/667

Drug-device combination products are medical devices, which consist of a device and active pharmaceutical ingredients that are physically or chemically combined together as a “single-entity”. These products lead to safer, effective management, and treatment of several disorders, owing to precise drug delivery, local administration, and individualized treatment. Major drug-device combination products include drug-eluting stents, infusion pumps, inhalers, transdermal delivery systems, prefilled syringes, and others. These technologically advanced products are used to manage and treat a number of chronic disorders such as cancer, diabetes, respiratory issues, cardiovascular disorders, wound healing, and others.

Market Dynamics

The growth of the global drug-device combination products market is driven by rise in incidence of chronic diseases such as diabetes, cancer, and respiratory problems, increase in casualties owing to accidents and trauma, rise in geriatric population, growth in home-based healthcare market, and technological advancements such as development of prefilled syringes. However, factors, such as unnoticed complications of drug-device combination products, number of product recalls, and stringent government regulations, hamper the market growth. Conversely, rise in healthcare infrastructure and high market potential in untapped emerging economies are expected to provide lucrative growth opportunities for the market.

Market Segmentation

The global drug-device combination products market is segmented based on product, application, end user, and region. On the basis of product, the market is segmented into drug-eluting stent, infusion pump, photodynamic therapy, antimicrobial wound dressing, prefilled syringe, drug-eluting balloon, nebulizer, inhaler, transdermal delivery system, and others.

Drug-eluting stents are further sub-segmented into coronary stents and peripheral vascular stents. The infusion pumps segment is further divided into implantable infusion pump, insulin infusion pump, patient-controlled analgesia pump, and ambulatory infusion pump. Similarly, prefilled syringes are further categorized into single-chamber prefilled syringes, dual-chamber prefilled syringes, and customized prefilled syringes. The drug-eluting balloon segment is bifurcated into coronary drug-eluting balloon and peripheral drug-eluting balloon. The inhaler segment is further segmented into drug powder inhaler (DPI), metered dose inhaler (MDI), and soft mist inhaler (SMI). Lastly, the transdermal delivery system segment is bifurcated into passive delivery system and active delivery system.

The transdermal delivery system segment accounted for the largest market share in 2017 and is expected to continue this trend throughout the forecast period. On the other hand, the prefilled syringe segment is anticipated to grow at a significant CAGR of 9.9% during the forecast period.

Do Purchase Enquiry : https://www.alliedmarketresearch.com/purchase-enquiry/667

Key Benefits for Stakeholders
• The study provides an in-depth analysis of the global drug-device combination products market with the current trends and future estimations from 2017 to 2025 to elucidate the imminent investment pockets.
• A comprehensive analysis of factors that drive and restrict the market growth is provided.
• Identification of factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on global & regional scales are provided.
• The key players are profiled, and their strategies are analyzed
thoroughly to understand the competitive outlook of the market.

Drug-Device Combination Products Market Key Segments:

By Product

• Drug-eluting stent

o Coronary drug-eluting stent
o Peripheral drug-eluting stent

• Infusion pump

o Implantable infusion pump
o Insulin infusion pump
o Patient-controlled analgesia pump
o Ambulatory infusion pump

• Photodynamic therapy
• Antimicrobial wound dressing
• Prefilled syringe

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David C
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.